Biomedical Science
Lab-Grown Sperm Breakthrough: Stem Cells Produce Early Human Sperm Cells in a Landmark Fertility Study
For millions of men worldwide, male infertility has been a condition without a cure — only workarounds. That may be changing. In a study published in Nature, researchers have for the first time generated immature human sperm cells from stem cells, using a living biological environment to nurture them through the earliest stages of development. The work represents a major step toward creating functional sperm in the laboratory.
How the procedure works
Germ cells — the cells that eventually become sperm — cannot develop on their own. They require a specific biochemical "niche" that provides the right signals at the right time. Recreating that niche in a petri dish has been one of the most stubborn challenges in reproductive biology. The research team's solution borrows from nature: they combined human induced pluripotent stem cells (iPSCs) with supportive cells taken from mouse fetuses, then transplanted the mixture into the kidney capsules of living mice.
The mouse kidney, rich in blood supply and growth factors, acted as a natural bioreactor. Over several weeks, the human stem cells differentiated into spermatogonia — the earliest stage of sperm development — and then progressed further into spermatocytes, which undergo meiosis, the cell-division process unique to gamete production. This is the furthest any lab-based system has progressed with human cells.
What it means for fertility treatment
Male infertility accounts for roughly half of all infertility cases globally, and about 1 in 100 men produce no sperm at all — a condition called azoospermia. Current treatment options are limited to surgical sperm extraction or donor sperm. If the lab-grown sperm approach can be advanced to produce fully mature, functional sperm cells capable of fertilising an egg, it would offer men with certain types of infertility a biological child of their own.
The researchers demonstrated functional potential by injecting the lab-grown human spermatocytes into mouse eggs in vitro. The cells fertilised the eggs and early embryos began forming, though development was not carried to term. Repeating this process with fully mature human sperm and tracking healthy development will require years of additional work.
Challenges that remain
Producing spermatocytes is not the same as producing functional sperm. The cells generated in this study are still immature — they have not completed the final transformation into motile, DNA-packed spermatozoa that can swim and penetrate an egg on their own. The next step is to create an artificial or biological environment that supports that final maturation. Researchers are exploring both microfluidic "testis-on-a-chip" systems and refined transplantation techniques to complete the process.
There are also questions about epigenetic imprinting — the chemical marks on DNA that are set during sperm development and influence embryo health. Lab-grown sperm may not carry the same imprinting patterns as naturally matured sperm, which could affect the viability of resulting embryos. Rigorous testing in animal models will be needed before any clinical application in humans.
Knowledge takeaway: Scientists used a mouse kidney as a living bioreactor to grow human stem cells into spermatocytes — the earliest stage of sperm — marking the most advanced lab-based production of human sperm cells to date. The lab-grown cells fertilised mouse eggs in vitro, forming early embryos. Full clinical application requires completing final maturation, verifying epigenetic imprinting, and years of animal-model safety testing.